These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36712613)

  • 1. Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Fujino M; Kurakami M; Onishi T; Boku S; Ishii T; Miura Y; Shinohara K; Kishihara Y; Ohashi N; Kotani O; Murakami T; Sato H; Tamamura H
    RSC Adv; 2023 Jan; 13(3):2156-2167. PubMed ID: 36712613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Boku S; Kurakami M; Fujino M; Ishii T; Miura Y; Nishimura S; Shinohara K; Yamamoto K; Bolah P; Kotani O; Murakami T; Sato H; Tamamura H
    Chem Pharm Bull (Tokyo); 2024; 72(1):41-47. PubMed ID: 38171903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Fujino M; Kurakami M; Boku S; Nakayama M; Kaneko M; Ohashi N; Kotani O; Murakami T; Sato H; Tamamura H
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33546092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
    Saito A; Yamashita M
    Retrovirology; 2021 Oct; 18(1):32. PubMed ID: 34702294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
    Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells.
    Sowd GA; Shi J; Aiken C
    J Virol; 2021 Nov; 95(24):e0144521. PubMed ID: 34613803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
    Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
    J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsid-Labelled HIV To Investigate the Role of Capsid during Nuclear Import and Integration.
    Zurnic Bönisch I; Dirix L; Lemmens V; Borrenberghs D; De Wit F; Vernaillen F; Rocha S; Christ F; Hendrix J; Hofkens J; Debyser Z
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid.
    Ning J; Zhong Z; Fischer DK; Harris G; Watkins SC; Ambrose Z; Zhang P
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
    Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
    Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket.
    Craveur P; Gres AT; Kirby KA; Liu D; Hammond JA; Deng Y; Forli S; Goodsell DS; Williamson JR; Sarafianos SG; Olson AJ
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.